Accordingly, ACPA-positive RA patients exhibit higher degrees of local and systemic bone damage (11–14) as well as reduced bone strength (15), and ACPA-positive individuals start showing periarticular bone loss in the absence of clinically evident synovitis (16). This evidence concerns the gene PRTN3 and rheumatoid arthritis.